readthroughSign in
CompanyADILNasdaqCharlottesville, VA

Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals develops AD04, a small molecule therapeutic for alcohol use disorder in genetically defined patient subpopulations, currently in Phase 3 clinical development.

8-KNov 12Latest SEC filing
Nov 16Latest story